Home > News > pSivida cancer cure ready for human testing
April 6th, 2004
pSivida cancer cure ready for human testing
Abstract:
pSivida Limited (PSD) today announced that its Singaporean subsidiary, pSiOncology Pte Ltd has successfully completed a final pre-clinical study for its lead BioSiliconTM product, BrachySilTM. This important and final pre-clinical milestone now paves the way for a ‘first in man’ evaluation of both BioSilicon and BrachySil, they announced. BrachySil is the Company’s lead product and is targeted to the substantial brachytherapy market, which is currently worth $600 million and expected to exceed US$1 billion by 2005.
Source:
egoli
Bookmark:
| Related News Press |
Nanomedicine
Ben-Gurion University of the Negev researchers several steps closer to harnessing patient's own T-cells to fight off cancer June 6th, 2025
Cambridge chemists discover simple way to build bigger molecules – one carbon at a time June 6th, 2025
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Self-propelled protein-based nanomotors for enhanced cancer therapy by inducing ferroptosis June 6th, 2025
Announcements
Electrifying results shed light on graphene foam as a potential material for lab grown cartilage June 6th, 2025
Quantum computers simulate fundamental physics: shedding light on the building blocks of nature June 6th, 2025
A 1960s idea inspires NBI researchers to study hitherto inaccessible quantum states June 6th, 2025
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||